Table 2:

Demographic, clinical, and QSM-related characteristics of the patient population

RRMSSPMSWhole Group
No.211536
Age (yr)36.2 ± 5.849.5 ± 9.240.5 ± 8.0
Disease duration (yr)9.7 ± 6.316.9 ± 7.012.7 ± 7.5
Sex (F/M)16:59:625:11
EDSS (mean) (range)2.0 (1.0–5.5)5.0 (4.0–7.0)3.0 (1.0–7.0)
No. of intracortical lesions (mean)
    Total4.5 ± 3.62.1 ± 2.63.5 ± 3.4
    QSM-hyperintense2.8 ± 2.30.9 ± 1.22.0 ± 2.1
    QSM-isointense0.6 ± 0.70.1 ± 0.40.4 ± 0.6
    QSM-hypointense1.1 ± 1.50.9 ± 1.81.0 ± 1.6
No. of leukocortical lesions (mean)
    Total2.6 ± 3.15.0 ± 3.53.6 ± 3.5
    QSM-hyperintense1.5 ± 1.81.9 ± 1.51.7 ± 1.7
    QSM-isointense0.5 ± 0.90.6 ± 1.30.5 ± 1.1
    QSM-hypointense0.5 ± 0.92.4 ± 2.41.3 ± 1.9
No. of total lesions (mean)
    Total7.1 ± 5.27.1 ± 5.07.1 ± 5.1
    QSM-hyperintense4.2 ± 3.42.8 ± 2.33.6 ± 3.0
    QSM-isointense1.0 ± 1.20.7 ± 1.30.9 ± 1.3
    QSM-hypointense1.6 ± 1.83.3 ± 3.72.3 ± 2.8